As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
The move represents a significant milestone in Lupin’s strategy to expand its specialty care portfolio and strengthen its presence in Europe
The center brings together hands on technology demonstrations, application expertise, and commercial operations
This makes VLCC the sole institution in the country authorised to conduct in-person NCLC exams
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
Sugammadex injection is bioequivalent to Merck’s Bridion injection for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery
The partnership has already launched with five active development programs, with both organizations jointly managing regulatory strategy and documentation under a structured, milestone-gated framework
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
STADA will market and distribute two EMA approved biosimilars developed by CuraTeQ in select European Union territories
Subscribe To Our Newsletter & Stay Updated
